Mr. Chris Aye joined Skyview in 2005 and is primarily responsible for financial due diligence, valuations and structure financing of a transaction.

Mr. Aye brings over 10 years of experience in finance and accounting, including six years of audit experience. Prior to joining Skyview, Mr. Aye served on various matrix teams at Amgen Inc. (the world's largest biotechnology company), including the successful $16 billion post-acquisition integration of Immunex Corp. Most recently, Mr. Aye held the key role of Financial Planning & Analysis, where he effectively co-managed a $150 million annual operating expense budget. Prior to Amgen, Mr. Aye served as a Senior Analyst in the M&A Transactions Group at Homestore.com, where he focused on financial and operational due diligence on potential acquisition targets. From 1998-2001, Mr. Aye was a CPA with Arthur Andersen LLP as a Senior Associate in the High Technology Audit Group, where he successfully advised start-up and emerging middle market technology companies through strategic M&A and IPO transactions.

Mr. Aye received a BA degree from the University of California, Santa Barbara, in Business Economics with a concentration in Accounting; and his MBA from the Marshall School of Business at the University of Southern California.

Mr. Aye also holds a CPA license in the State of California, and has been an active member of the American Institute of Certified Public Accountants.